CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 219 enrolled
Drug / intervention
Acarbose +1 moredrug
Likely dose
Acarbose 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01470937
NCT01470937Phase 4Completed
CompareCT.gov

Early Diabetes Intervention Program

Indiana University·interventional·Posted Nov 11, 2011·Updated Nov 11, 2011

In Brief

A Phase 4 clinical trial evaluating Acarbose and Placebo for Type 2 Diabetes Mellitus. Completed, enrolled 219 participants across 1 site.

Detailed Summary

This is an evaluation of the effect of acarbose to delay worsening of fasting glucose control in early Type 2 diabetes mellitus.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesUnited States
CollaboratorsBayer

Timeline

Phase 4CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 11, 2011
Enrollment StartFeb 1, 1998
Primary CompletionSep 1, 2004
TodayJul 2, 2026
Enrollment to primary: 6.6 yearsPosted 14.6 years ago

Interventions

Acarbosedrug

acarbose 100 mg PO once daily

Placebodrug

acarbose placebo